Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1426 |
TCP
Tourbillon Capital Partners
New York
| $0 | -$56.7M | 0 | – | Closed |
|
| 1427 |
TNBTD
Trustmark National Bank Trust Department
Jackson,
Mississippi
| $0 | -$242K | 0 | – | Closed |
|
| 1428 |
TS
Twin Securities
New York
| $0 | -$660K | 0 | – | Closed |
|
| 1429 |
UMA
USA Mutuals Advisors
Dallas,
Texas
| $0 | -$2K | 0 | – | Closed |
|
| 1430 |
VF
Virtu Financial
New York
| $0 | -$245K | 0 | – | Closed |
|
| 1431 |
WI
WBI Investments
Red Bank,
New Jersey
| $0 | -$1.08M | 0 | – | Closed |
|
| 1432 |
WCM
Wealthcare Capital Management
Richmond,
Virginia
| $0 | -$3K | 0 | – | Closed |
|
| 1433 |
WP
WMS Partners
Towson,
Maryland
| $0 | -$529K | 0 | – | Closed |
|
| 1434 |
Zacks Investment Management
Chicago,
Illinois
| $0 | -$552K | 0 | – | Closed |
|